Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -113.41% | -126.19% | -12.63% | -37.21% | -58.90% |
| Total Depreciation and Amortization | 0.87% | -3.02% | -4.70% | -0.44% | 0.44% |
| Total Amortization of Deferred Charges | -9.09% | -5.88% | 35.14% | 126.09% | 511.11% |
| Total Other Non-Cash Items | 578.78% | 649.58% | -25.59% | 24.02% | 41.30% |
| Change in Net Operating Assets | 68.27% | -99.54% | -78.08% | -276.87% | 80.28% |
| Cash from Operations | -8.27% | -18.38% | -27.38% | -66.16% | -63.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -826.85% | -414.70% | 188.33% | 128.31% | 151.41% |
| Cash from Investing | -827.13% | -414.73% | 188.33% | 128.32% | 151.40% |
| Total Debt Issued | -- | -49.05% | -49.05% | -49.05% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 320.49% | 312.92% | 5,281.27% | -18.34% | -18.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 327.29% | 429.07% | 779.78% | 6.18% | -3.97% |
| Foreign Exchange rate Adjustments | 250.00% | -- | 300.00% | -- | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.21% | -109.97% | 128.62% | 389.62% | 315.15% |